NAVIDEA BIOPHARMACEUTICALS, INC. Note Agreements

23 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended and Restated Secured Term Note between Navidea Biopharmaceuticals, Inc. and John K. Scott, Jr. dated November 27, 2023
Note Agreements
NAVIDEA BIOPHARMACEUTICALS, INC.
Biotechnology
2023
Secured Convertible Promissory Note between Navidea Biopharmaceuticals, Inc. and John K. Scott, Jr.
Note Agreements
NAVIDEA BIOPHARMACEUTICALS, INC.
Biotechnology
2023
Secured Bridge Note between Navidea Biopharmaceuticals, Inc. and John K. Scott, Jr. dated April 25, 2023
Note Agreements
NAVIDEA BIOPHARMACEUTICALS, INC.
Biotechnology
2023
Secured Term Note between Navidea Biopharmaceuticals, Inc. and John K. Scott, Jr. dated April 10, 2022
Note Agreements
NAVIDEA BIOPHARMACEUTICALS, INC.
Biotechnology
CO
2022
Amended and Restated Promissory Note (Term Loan Facility) between Navidea Biopharmaceuticals, Inc. and Platinum-Montaur Life Sciences LLC
Note Agreements
NAVIDEA BIOPHARMACEUTICALS, INC.
Biotechnology
2013
Amended and Restated 10% Series B Senior Secured Convertible Promissory Note between Neoprobe Corporation and Platinum-Montaur Life Sciences, LLC
Note Agreements
NAVIDEA BIOPHARMACEUTICALS, INC.
Biotechnology
NY
2009
Amended and Restated 10% Series A Senior Secured Convertible Promissory Note between Neoprobe Corporation and Platinum-Montaur Life Sciences, LLC
Note Agreements
NAVIDEA BIOPHARMACEUTICALS, INC.
Biotechnology
NY
2009
NeoProbe Corporation Amended 10% Convertible Note Due December 31, 2011
Note Agreements
NAVIDEA BIOPHARMACEUTICALS, INC.
Biotechnology
2008
Third Amended and Restated Promissory Note (Term Loan Facility) between Navidea Biopharmaceuticals, Inc. and Platinum-Montaur Life Sciences LLC
Note Agreements
NAVIDEA BIOPHARMACEUTICALS, INC.
Biotechnology
2015
Promissory Note between Navidea Biopharmaceuticals Inc. and R-NAV, LLC dated July 15, 2014
Note Agreements
NAVIDEA BIOPHARMACEUTICALS, INC.
Biotechnology
DE
2014
Second Amended and Restated Promissory Note (Term Loan Facility) between Navidea Biopharmaceuticals, Inc. and Platinum-Montaur Life Sciences LLC
Note Agreements
NAVIDEA BIOPHARMACEUTICALS, INC.
Biotechnology
2014
Promissory Note (Term Loan Facility) between Navidea Biopharmaceuticals, Inc. and Platinum-Montaur Life Sciences LLC
Note Agreements
NAVIDEA BIOPHARMACEUTICALS, INC.
Biotechnology
2012
Second Amendment to 10% Series A Senior Secured Convertible Promissory Note between Neoprobe Corporation and Platinum-Montaur Life Sciences, LLC
Note Agreements
NAVIDEA BIOPHARMACEUTICALS, INC.
Biotechnology
NY
2008
NeoProbe Corporation 10% Series B Senior Secured Convertible Promissory Note with Platinum-Montaur Life Sciences, LLC
Note Agreements
NAVIDEA BIOPHARMACEUTICALS, INC.
Biotechnology
NY
2008
Amendment to 10% Convertible Note Purchase Agreement between Neoprobe Corporation and Purchasers (December 26, 2007)
Note Agreements
NAVIDEA BIOPHARMACEUTICALS, INC.
Biotechnology
DE
2008
10% Series B Senior Secured Convertible Promissory Note between Neoprobe Corporation and Platinum-Montaur Life Sciences, LLC
Note Agreements
NAVIDEA BIOPHARMACEUTICALS, INC.
Biotechnology
NY
2008
NeoProbe Corporation 10% Series A Senior Secured Convertible Promissory Note with Platinum-Montaur Life Sciences, LLC
Note Agreements
NAVIDEA BIOPHARMACEUTICALS, INC.
Biotechnology
NY
2008
NeoProbe Corporation 10% Convertible Note Due July 8, 2008 (David C. Bupp, Cynthia B. Gochoco, and Walter H. Bupp)
Note Agreements
NAVIDEA BIOPHARMACEUTICALS, INC.
Biotechnology
2007
10% Convertible Note Purchase Agreement between Neoprobe Corporation and Purchasers (July 3, 2007)
Note Agreements
NAVIDEA BIOPHARMACEUTICALS, INC.
Biotechnology
2007
Schedule Identifying Omitted Documents Related to Neoprobe Corporation Replacement Notes and Warrants
Note Agreements
NAVIDEA BIOPHARMACEUTICALS, INC.
Biotechnology
2006
NeoProbe Corporation Series A Convertible Promissory Note Due January 7, 2009
Note Agreements
NAVIDEA BIOPHARMACEUTICALS, INC.
Biotechnology
2006
Schedule of Omitted Documents for Neoprobe Corporation 8% Series A Convertible Promissory Notes and Common Stock Purchase Warrants
Note Agreements
NAVIDEA BIOPHARMACEUTICALS, INC.
Biotechnology
2004
NeoProbe Corporation 8% Series A Convertible Promissory Note Due December 12, 2008
Note Agreements
NAVIDEA BIOPHARMACEUTICALS, INC.
Biotechnology
DE
2004